Accessibility Menu
Vigil Neuroscience logo

Vigil Neuroscience

(NASDAQ) VIGL

Current PriceN/A
Market CapN/A
Since IPO (2022)-36%
5 YearN/A
1 Year+104%
1 Month+1%

Vigil Neuroscience Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$452.00K

Net Income (TTM)

$92.17M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

VIGL News

No articles available.

VIGL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vigil Neuroscience

Industry

Biotechnology

Employees

69

CEO

Ivana Magovcevic-Liebisch, PhD

Headquarters

Watertown, MA 02142, US

VIGL Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-214%

Net Income Margin

-204%

Return on Equity

-1%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$453.00K

Operating Income

$89.68M

EBITDA

$83.80M

Operating Cash Flow

$51.22M

Capital Expenditure

$5.00K

Free Cash Flow

$51.23M

Cash & ST Invst.

$97.80M

Total Debt

$12.95M

Vigil Neuroscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

69

N/A

Net Income

$26.66M

-25.6%

EBITDA

$27.36M

-22.3%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$54.55M

-25.6%

Accounts Receivable

$558.00K

+5.3%

Inventory

$0.00

N/A

Long Term Debt

$11.33M

-8.9%

Short Term Debt

$2.21M

+128.3%

Return on Assets

-1.06%

N/A

Return on Invested Capital

-1.84%

N/A

Free Cash Flow

$20.55M

-32.5%

Operating Cash Flow

$20.48M

-32.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ORTXOrchard Therapeutics plc
$16.70+0.30%
CKPTCheckpoint Therapeutics, Inc.
$4.26+0.00%
RVNCRevance Therapeutics, Inc.
$3.65+0.00%
GTHXG1 Therapeutics, Inc.
$7.16+0.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.35+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
QQQInvesco QQQ Trust
$593.02-0.00%

Questions About VIGL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.